Physician profile
Robert Claypool
NPI 1376872036
$1,372.57
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.31 · 2021: $628 · 2022: $14.71 · 2023: $655 · 2024: $46.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533 · Gift: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.88 |
| Gift | $168.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $501.38 | 2022-2023 | Endo Activator, Orthophos E |
| Zimmer Biomet Holdings, INC. | $450.00 | 2021 | |
| Ultradent Products INC | $168.53 | 2023 | Opalescence |
| Straumann USA LLC | $115.92 | 2021 | |
| Kerr Corporation | $48.86 | 2021 | |
| Ivoclar Vivadent, INC. | $28.31 | 2020 | |
| Geistlich Pharma, North America, INC. | $27.99 | 2024 | Geistlich Bio-Gide |
| Envista Holdings Corporation | $18.22 | 2024 | Endo Ring |
| Orapharma, A Division of Bausch Health US, LLC | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Claypool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.